first in class - Robuta Search

https://www.ispor.org/vih-articles/Volume-20--Issue-9/Assessing-The-Cost-Effectiveness-Of-A-New--First-In-Class-Triple-Fixed-Dose-Combination-Therapy-For-COPD-Patients Assessing The Cost Effectiveness Of A New, First-In-Class Triple Fixed Dose Combination Therapy For... first in class the cost combination therapy assessing effectiveness https://www.inknowvation.com/sbir/awards/nih-2023-kv21-targeted-first-class-neuroprotective-therapeutic-acute-ischemic-stroke NIH 2023 Kv2.1-Targeted First in Class Neuroprotective Therapeutic for Acute Ischemic Stroke |... first in class acute ischemic stroke nih targeted neuroprotective https://egrove.olemiss.edu/etd/3270/ "Part 1: First-In-Class Amino Acid Mimetics Small Molecules as Antifung" by Mario Djugovski Opportunistic fungal pathogens, such as Cryptococcus neoformans, pose a significant public health risk, particularly for immunocompromised individuals. C.... first in class amino acid small molecules part mimetics https://www.natap.org/2015/AASLD/AASLD_84.htm Phase 1b Efficacy and Safety of NVR 3-778, a First-In-Class HBV Core Inhibitor, in HBeAg-Positive... first in class phase efficacy safety nvr https://defence.newsd.in/military/navy/india-hands-over-first-in-class-diving-support-craft-dsc-a20-to-navy India Hands Over First in Class Diving Support Craft DSC A20 to Navy Sep 18, 2025 - India DSC A20: The Indian Navy got a big upgrade in its underwater work after getting DSC A20, which is the very first Diving first in class india hands diving support https://zedira.com/News/Zedira-publication-Features-of-ZED1227-The-First-In-Class-Tissue-Transglutaminase-Inhibitor-Undergoing-Clinical-Evaluation-for-the-Treatment-of-Celiac-Disease_138?oswsid=5360bc93c450b0a2e837bae710d7c458 Zedira publication - Features of ZED1227: The First-In-Class Tissue Transglutaminase ... - 2022 -... Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and ... first in class publication features tissue transglutaminase https://www.prnewswire.co.uk/news-releases/sanofi-and-regeneron-report-phase-2-data-for-potential-first-in-class-lipid-lowering-pcsk9-antibody-144606235.html Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 Antibody /PRNewswire/ -- - New Data Presented at American College of Cardiology Meeting Demonstrate Reductions of 40% to 72% in LDL-Cholesterol in Patients on Statins... first in class sanofi regeneron report phase https://www.pasteur.fr/en/institut-pasteur-and-stragen-sign-exclusive-worldwide-license-agreement-first-class-pain-management-0?language=fr The Institut Pasteur and Stragen sign an exclusive worldwide license agreement for first-in-class... Oct 14, 2016 - The Institut Pasteur, a private non-profit international biomedical research center based in Paris (France), and Stragen, privately-owned, international... first in class institut pasteur an exclusive license agreement sign https://www.biontech.com/int/en/home/mediaroom/news/press-releases/2022/04/biontech-presents-positive-preliminary-phase-12-data-first-class.html BioNTech Presents Positive Preliminary Phase 1/2 Data for First-in-Class CAR-T Program BNT211 at... first in class preliminary phase biontech presents positive https://flutrackers.com/forum/forum/welcome-to-the-scientific-library/treatments/988827-j-med-chem-discovery-of-first-in-class-protac-degraders-of-sars-cov-2-main-protease?view=media J Med Chem . Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease - FluTrackers... J Med Chem . 2024 Apr 12. doi: 10.1021/acs.jmedchem.3c02416. Online ahead of print. Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease... first in class protac degraders j med chem https://repository.arizona.edu/handle/10150/677003 Discovery of DYR684, a First-in-Class DYRK1A/B PROTAC first in class discovery b protac https://www.globaljournalobserver.com/article/907153774-remix-therapeutics-announces-oral-presentation-of-first-in-class-small-molecule-myb-mrna-degrader-rem-422-phase-1-2-aria-trial-results-at-the-2026 Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader... Global Journal Observer is an online news publication focusing on the World: Get your daily news on global issues first in class small molecule remix therapeutics announces https://www.attovia.com/ Attovia: Shaping the future of I&I with first-in-class multispecifics Dec 20, 2025 - Harnessing ATTOBODY technology to bring treatments to patients where none exist or where current solutions fall short. shaping the future first class https://www.vetbiolix.com/ Vetbiolix | Veterinary Biotech | First-in-Class Pet Treatments first in class veterinary biotech pet treatments https://wyss.harvard.edu/news/ropirio-launches-from-wyss-institute-to-develop-first-in-class-lymphatic-medicines/ Ropirio launches from Wyss Institute to develop first-in-class lymphatic medicines Sep 10, 2024 - The company is leveraging a discovery program developed at Harvard and Boston University to treat a wide range of serious diseases first in class wyss institute launches develop lymphatic https://researchr.org/publication/CuadradoRL22 A First-in-Class Block-Based Programming Language Distance Calculation - researchr publication first in class programming language distance calculation block based https://www.aramis.admin.ch/Beteiligte/?ProjectID=59986 Towards first-in-class siRNA therapeutics for adrenal targets - Participants first in class towards sirna therapeutics adrenal https://www.bioworld.com/articles/705729-first-in-class-vav1-inhibitor-prevents-colitis-progression-in-experimental-model?v=preview First-in-class VAV1 inhibitor prevents colitis progression in experimental model | BioWorld Proto-oncogene Vav (VAV1) is a guanine exchange factor that is crucial for T- and B-cell receptor signaling. Assays in Vav1-knockout murine models had... first in class inhibitor colitis progression experimental https://www.cirm.ca.gov/our-progress/awards/first-class-crispr-casx-gene-editor-silencing-apoc3-transcription-treatment-severe-hypertriglyceridemia/ A first-in-class CRISPR-CasX gene editor silencing APOC3 transcription for the treatment of Severe... first in class for the crispr casx gene https://ymmuno.bio/ Ymmunobio AG | First-in-Class Solid Tumor Therapeutics Apr 28, 2026 - Ymmunobio AG develops first-in-class therapeutics for solid tumors, targeting NPTXR, a tumor-exclusive marker found in 17+ major cancer types. first in class ag solid tumor therapeutics https://www.orega-biotech.com/ OREGA Biotech — first-in-class antibodies for cancer immunotherapy OREGA Biotech discovers and develops first-in-class monoclonal antibodies for cancer immunotherapy. IPH5201 (anti-CD39) is in Phase 2 in early-stage NSCLC. first in class cancer immunotherapy biotech antibodies https://www.consultantlive.com/view/expert-perspectives-on-first-in-class-il-23-oral-peptide Expert Perspectives on First-In-Class IL-23 Oral Peptide Examination of unique challenges and the importance of early, effective therapy in younger patients. first in class expert perspectives il oral peptide https://www.biospace.com/press-releases/asco-2025-oral-presentation-innovent-biologics-announces-updated-data-of-ibi363-first-in-class-pd-1-il-2%CE%B1-bias-bispecific-antibody-fusion-protein-from-phase-1-and-2-clinical-studies-on-immunotherapy-treated-advanced-malignant-melanoma ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class... first in class asco oral presentation biologics https://xtalks.com/niktimvo-axatilimab-approved-as-first-in-class-therapy-for-chronic-gvhd-3777/ Niktimvo (Axatilimab) Approved as First-in-Class Therapy for Chronic GVHD - Xtalks Feb 19, 2025 - Niktimvo (axatilimab) is the first anti-CSF-1R antibody that targets the inflammation and fibrosis driving chronic GVHD. first in class approved therapy chronic gvhd https://thepharmadata.com/first-in-class-targeted-microrna-therapy-slows-cancer-tumor-growth/ First-in-class Targeted MicroRNA Therapy Slows Cancer Tumor Growth | The Pharma Data Sep 6, 2023 - First-in-class targeted microRNA therapy slows cancer tumor growth first in class pharma data targeted microrna therapy https://www.mednous.com/global-oncology-has-many-first-class-compounds Global oncology has many first-in-class compounds | MedNous first in class global oncology many compounds https://ouci.dntb.gov.ua/en/works/7BoDpnP4/ Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading... first in class design synthesis biological evaluation https://www.creativebio.tech/ CBT | First in Class Biotech Creative BioTherapeutics is an emerging Biotech that focuses on the root cause of drug resistance and immune evasion for cancer, viruses and other illnesses.... first in class cbt biotech https://ricerca.univaq.it/handle/11697/124016 The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects... first in class inhibitor molecule shows effects https://lipum.se/ Lipum - We develop an anti-inflammatory drug with first-in-class potential Mar 24, 2026 - Lipum is a biopharmaceutical company specialized on a novel way to treat chronic inflammatory diseases. first in class we develop anti inflammatory drug potential https://pure.ul.ie/en/publications/first-in-class-thyrotropin-releasing-hormone-trh-based-compound-b/ First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically... first in class releasing hormone trh based https://www.prnewswire.com/news-releases/fapon-biopharma-announces-fda-approval-of-ind-for-fp008-a-first-in-class-immunotherapy-for-solid-tumors-302388341.html Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid... /PRNewswire/ -- Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and... first in class fda approval biopharma announces ind https://hub-xchange.com/news-xchange-articles/mindwalk-advances-ai-designed-glp-1-program-first-class-dual-pathway-regimen-aging-longevity MindWalk Advances AI-Designed GLP-1 Program With First-in-Class Dual-Pathway Regimen for Aging and... first in class advances ai designed glp https://vivacetherapeutics.com/ Vivace | Turning novel biology into first-in-class cancer therapeutics May 7, 2026 - Vivace Therapeutics is an oncology-focused small molecule drug discovery and development company adopting a capital-efficient approach to bring novel therapies... first in class cancer therapeutics vivace turning novel https://cordis.europa.eu/project/id/889219/reporting/es Assessing the feasibility of MT-011, a first-in-class drug to treat glaucoma and other... Latest report summary first in class assessing feasibility mt drug https://acir.org/weekly-digests/2021/december/first-in-class-vaccine-against-ido-and-pd-l1-enhances-anti-pd-1-in-phase-i-ii-clinical-trial First-in-class vaccine against IDO and PD-L1 enhances anti-PD-1 in phase I/II clinical trial In a phase I/II clinical trial, 30 anti-PD-1-naive patients with metastatic melanoma were treated with a first-in-class immunomodulatory vaccine (IO102/IO103)... first in class clinical trial vaccine ido pd https://www.imtm.cz/publication/impact-factor-journals/baxdrostat-first-class-aldosterone-synthase-inhibitor-resistant?language=cs Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension | Institute... first in class aldosterone inhibitor resistant hypertension https://www.techtransfer.nih.gov/tech/tab-5058 First in class Small Molecule Agonists of the mammalian Relaxin family receptor 1 (RXFP1) and use... first in class small molecule agonists mammalian relaxin https://research.abo.fi/sv/publications/heparin-binding-motif-mutations-of-human-diamine-oxidase-allow-th/fingerprints/?sortBy=alphabetically Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class... first in class the development heparin binding motif https://www.bergenbio.com/ BerGenBio - Developing first-in-class AXL inhibitors for aggressive disease BerGenBio: Developing first-in-class AXL inhibitors for aggressive diseases, including advanced, treatment resistant cancers first in class developing axl inhibitors aggressive https://www.jnj.com/media-center/press-releases/janssen-presents-updated-results-evaluating-first-in-class-gprc5d-bispecific-antibody-talquetamab-in-heavily-pretreated-patients-with-multiple-myeloma Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab... Jul 18, 2025 - Updated results for talquetamab monotherapy and in combination with daratumumab highlighted in oral presentations at the 2022 EHA Annual Congress first in class updated results bispecific antibody janssen presents https://www.almacgroup.com/news/almac-discovery-nominates-alm-401-as-a-first-in-class-bispecific-next-generation-adc/?cc=US Almac Discovery nominates ALM-401 as a First in Class Bispecific Next Generation ADC targeting... Jun 10, 2024 - ALM-401 has been designed to be half the size of a conventional ADC to promote improved tumour penetration and ease of manufacture. first in class almac discovery next generation bispecific adc https://biopharmaboardroom.com/news/11/3649/bayer-and-kumquat-biosciences-partner-to-develop-first-in-class-kras-g12d-inhibitor-for-hard-to-treat-cancers.html Bayer and Kumquat Biosciences Partner to Develop First-in-Class KRAS G12D Inhibitor for... Bayer and Kumquat Biosciences Partner to Develop First-in-Class KRAS G12D Inhibitor for Hard-to-Treat Cancers first in class bayer kumquat biosciences partner https://www.moderntiredealer.com/industry-news/retail/article/11527009/team-falken-win-first-in-class-at-watkins-glen-six-hour-2015-06-29 Team Falken win first in class at Watkins Glen Six-Hour | 2015-06-29 | Modern Tire Dealer Team Falken and its tenacious duo of drivers, Wolf Henzler and Bryan Sellers, aboard their durable Porsche 911 RSR, reaffirmed their endurance skills with... first in class modern tire dealer watkins glen team falken https://prosale.com/ Estate Sale Software | PROSALE | First in Class Estate Sale Management Software with point of sale, inventory management, online sales with e-commerce, credit card payments, barcoding, labels, and more.... first in class estate sale software https://myosintherapeutics.com/ Myosin Therapeutics: First-in-Class Molecular Motor Therapies Advancing first-in-class therapies by targeting molecular motors (NMII) in oncology and neuroscience. Learn about our clinical trials for GBM, PDAC, and SUD. first in class myosin therapeutics molecular motor https://ricerca.unich.it/handle/11564/855810 A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted... first in class based on non cytotoxic recombinant https://www.pepkon.fr/ PepKon - first-in-class peptides in oncology, inspired by human biology Pepkon is a biotech company developing a therapeutic peptide platform in oncology. Its lead candidate is an agonist peptide targeting the TSP-1/CD47 pathway. first in class inspired by human biology peptides oncology https://www.oxfordbiotherapeutics.com/ Developing First-in-Class Cancer Therapies | Oxford BioTherapeutics At Oxford BioTherapeutics, we are dedicated to pioneering the next generation of oncology treatments through targeted therapies, including Antibody-Drug... first in class cancer therapies developing oxford biotherapeutics https://www.mdanderson.org/newsroom/archived-news/first-in-class-drug-.h00-159063978.html ARCHIVED: First-in-class drug ONC201shows potential for some blood cancers | UT MD Anderson ONC201, an anti-cancer drug that triggers cell death in various tumor types, may have clinical potential for some blood cancers including mantel cell lymphoma... first in class ut md anderson blood cancers archived drug https://www.genedata.com/resources/learn/details/poster/request-management-module-to-increase-biotherapeutics-rd-operational-efficiency A First-in-Class Request Management Module to Increase Biotherapeutics R&D Operational Efficiency first in class request management operational efficiency module increase https://research.universityofgalway.ie/en/publications/activity-of-mln4924-a-novel-first-in-class-small-molecule-inhibit-3/ ACTIVITY OF MLN4924, A NOVEL FIRST IN CLASS SMALL MOLECULE INHIBITOR OF THE NEDD8 ACTIVATING... first in class small molecule activity novel inhibitor https://merit.url.edu/ca/publications/design-and-functional-characterization-of-a-first-in-class-irreve/ Design and functional characterization of a first-in-class irreversible inhibitor of... first in class functional characterization design irreversible inhibitor https://www.raps.org/resource/study-fda-offers-flexibility-expedited-review-to.html Study: FDA offers flexibility, expedited review to first-in-class drugs more often than EMA | RAPS The US Food and Drug Administration (FDA) is more likely to offer regulatory flexibility and grant expedited review to first-in-class drugs than the European... first in class study fda offers flexibility https://www.ipsen.com/event/key-opinion-leader-kol-call-dedicated-to-corabotase-ipn10200-our-first-in-class-a-b-recombinant-neuromodulator/ Key Opinion Leader (KOL) call dedicated to corabotase (IPN10200), our first-in-class Recombinant... key opinion leader kol call dedicated first https://biotechdispatch.com.au/news/kazia-licenses-global-rights Kazia licenses global rights to potential first-in-class oncology drug - Biotech Kazia Therapeutics (ASX:KZA) has entered into a worldwide exclusive licensing agreement and a master services agreement with European company Evotec SE for... first in class licenses global rights potential https://pharmaphorum.com/news/senju-launches-first-class-dry-eye-disease-drug-japan Senju launches first-in-class dry eye disease drug in Japan | pharmaphorum Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market. first in class dry eye disease launches drug japan https://pubs.rsc.org/en/content/articlelanding/2019/mt/c9mt00051h First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death... The ruthenium complex sodium trans-[tetrachloridobis(1H-indazole)ruthenate(iii)] (KP1339/IT-139) showed preclinical activity in a variety of in vivo tumor... first in class cell death ruthenium anticancer drug https://www.novochizol.ch/ Novochizol | First-in-class polysaccharide nanospheres. Aug 3, 2025 - Novochizol SA is a Swiss biotech company with a unique chitosan-based drug formulation, first-in-class polysaccharide nanospheres. first in class polysaccharide https://www.hepb.org/index.php/news-and-events/news-2/german-scientist-inventor-of-worlds-first-treatment-for-hepatitis-d-to-receive-the-2023-baruch-s-blumberg-prize/ German scientist, inventor of new, first-in-class treatment for hepatitis D, to receive the 2023... first in class treatment for hepatitis d german scientist https://www.unibestpharm.com/Trilaciclib-The-First-in-Class-Myeoprotection-Market-Advantages-and-Competitions-id69435317.html Trilaciclib, The First-in-Class Myeoprotection: Market, Advantages, and Competitions - Unibest... Trilaciclib, The First-in-Class Myeoprotection: Market, Advantages, and Competitions, Unibest Industrial Co., Ltd. first in class market advantages competitions https://catalystalert.io/news/0ba35f02-54c8-4855-a52e-c84830db79ad New First-in-Class Therapy for Chronic Graft-Versus-Host Disease Approved in Australia[1] |... May 3, 2026 - NIKTIMVO (axatilimab), a first-in-class therapy for chronic graft-versus-host disease, has been approved by Australia's TGA under Priority Review, making Austra first in class new therapy chronic graft https://sunbeltmidwest.com/blog/sunbelt-business-advisors-awards Sunbelt Business Advisors Of Minnesota Sweeps First-In-Class Team Awards from International... Sunbelt Business Advisors Of Minnesota Sweeps First-In-Class Team Awards from International Business Brokers Association first in class business advisors team awards sunbelt minnesota https://www.mitorxtherapeutics.com/ MitoRx Therapeutics - First-in-class mitochondrial protective therapeutics Developing small molecule therapeutics modulating mitochondrial metabolism for weight loss to drive fat loss without any lean mass loss in cardiometabolic... first in class therapeutics mitochondrial protective https://www.shephardmedia.com/news/naval-warfare/india-receives-first-of-class-p15b-destroyer/ India receives first-in-class P15B destroyer | Shephard The Indian Navy should commission its first Visakhapatnam-class destroyer shortly after it was handed over by its shipbuilder. first in class india receives destroyer shephard https://www.denteric.com/ Denteric: First-in-class therapeutic for treating chronic inflammation first in class chronic inflammation therapeutic treating https://www.deutsche-apotheker-zeitung.de/daz-az/2022/daz-1-2022/first-in-class-avacopan First-in-Class: Avacopan - Deutsche Apotheker Zeitung first in class deutsche apotheker zeitung https://www.cancerresearch.org/blog/fda-approves-first-car-t-cell-immunotherapy FDA Approves First-In-Class CAR T Cell Immunotherapy for Leukemia - Cancer Research Institute Dec 14, 2022 - Children and young adults with relapsed/refractory acute lymphoblastic leukemia (ALL) can now receive the CD19-targeting CAR T cell immunotherapy Kymriah first in class cancer research institute fda approves car https://www.polyu.edu.hk/media/media-releases/2023/0522_polyu-and-cuhk-jointly-develop-abarginase-the-first-in-class-drug/ PolyU and CUHK jointly develop ABarginase, the first-in-class drug for multiple obesity-related... May 22, 2023 - PolyU and CUHK jointly develop ABarginase, the first-in-class drug for multiple obesity-related metabolic diseases first in class develop drug multiple obesity https://corporate.dukehealth.org/news/first-class-compound-proves-safe-tolerable-preventing-blood-clots First-in-Class Compound Proves Safe, Tolerable in Preventing Blood Clots | Duke Health A new drug derived from magnolia trees appears to be able to uncouple two important functions of thrombin in blood clot formation and may offer a way to better... first in class blood clots duke health compound proves https://www.altevax.com/ Altevax | A first-in-class immunotherapy against cancer Using melanin as an adjuvant, Altevax has developed an immunotherapy that triggers a strong antigen-specific immune response of CD8+ and CD4+ T cells. Altevax... first in class immunotherapy cancer https://liveforever.club/resources/inflarx-takes-on-inflammation-with-first-in-class-c5a-c5ar-signaling-pathway-strategy InflaRx takes on inflammation with first-in-class C5a/C5aR signaling pathway strategy Podcast from Beyond Biotech-InflaRx Tackles Inflammation via First-of-its-Kind C5a/C5aR Pathway Strategy first in class signaling pathway takes inflammation strategy